On September 3, 2018, the 3D printing industry created another acquisition of up to 1.4 billion U.S. dollars, Virginia medical equipment manufacturer K2M will be struck by the Fortune 500 medical technology company Stryker Corporation (New York Stock Exchange) Stock Code: SYK) Acquisition. Both companies apply 3D printing technology to the production of spinal implants. In terms of acquisitions, K2M will become a wholly-owned subsidiary of Stryker at a purchase price of $ 27.50 per share, with a purchase amount of $ 1.4 billion (about 9.5 billion yuan). ).
Stryker's 2017 revenue was US $ 11.325 billion. Founded in 1941, Stryker is one of the world's most orthopaedic and medical technology companies.Headquartered in Cramamasu, Michigan, the United States has 14 production R & D and sales divisions, with more than 16,000 employees.
So what exactly does K2M do? It's so valuable. According to Antarctic Bear, K2M has several FDA-approved 3D printed implants. In 2016, the company's two 3D printed spine solutions-CASCADIACervical (cervical spine) and CASCADIAANLordoticOblique (anterior oblique) obtained US Food and Drug Administration. Agency (FDA) sales permission. In 2017, they have another new product for spinal support-MOJAVEPL-obtained the US Food and Drug Administration (FDA) license.
Stryker Chairman and Executive Officer Kevin A. Lobo commented: "We believe that K2M will significantly enhance our relationship with spine and neurosurgeons, patients and employees."
3D printed spinal implants
Founded in 1941, Stryker distributes a wide range of products, from implants for joint replacement to surgical navigation systems. The company's 3D printing technology is sold in the Tritanium (titanium alloy) spinal implant series, which has been repeatedly approved by the FDA for a variety of applications. Stryker's 3D printed Tritanium implants are porous and help promote the growth of cellular tissue.
In the most recent partnership, Stryker became a distributor of 3DSystems' Virtual Surgery Plan (VSP) and 3D printed anatomical models.
K2M was founded in 2004. The company's products include minimally invasive implants, such as adjustable MOJAVE3D printed spinal support implants, biologics, and treatments for complex spinal injuries, such as the CAPRI cage system, which has recently been CE certified in Denmark.
$ 10 billion opportunity
Stryker's acquisition of K2M is expected to be completed by the end of the fourth quarter of 2018, depending on customary closing conditions and shareholder / regulatory approvals. The transaction has so far been approved by the boards of both companies.
According to K2M Chairman, * Executive Officer and President EricD. Major, "Joining Stryker will be the next chapter for our global team and global surgeon customers. Stryker's leadership in the plastic and neurosurgery market, plus K2M's Complex spine and minimally invasive solutions provide Stryker with a strong opportunity to strengthen its leadership position in the global $ 10 billion spine market. "